Air India Ltd. will conduct a one-time drug test for its 5,000+ pilots following a mid-air incident where a captain allegedly tested positive for illegal drugs, per an internal email. The mandatory screening, effective August 13, 2026, covers all pilots across Air India and Air India Express fleets, targeting psychoactive substances or medications violating regulations. This action stems from the Phuket-Delhi flight mishap, though details about the captain’s identity or the incident remain undisclosed. Pilots received the directive via email, emphasizing compliance with safety protocols.

The test’s scope is broader than typical screenings, focusing on substances prohibited under aviation rules. Air India, India’s flagship carrier, aims to preempt risks linked to substance use, though no prior large-scale testing was reported. The move reflects heightened scrutiny post-incident, with no mention of disciplinary actions beyond the test.

Air India Express, the low-cost subsidiary, is included in the directive, signaling company-wide commitment to safety. The date August 13 marks the deadline for pilots to comply. While specifics on testing methods or penalties are absent, the email underscores regulatory adherence. This unprecedented step underscores Air India’s proactive approach to aviation safety amidst rising global concerns about pilot health.